Ads
related to: diabetes, food and drug administration- What Is Time In Range?
Discover How To Use This Metric
To Help Your Patients.
- What Do Experts Think?
Read Experts' Opinions
For Deeper Diabetes Insights
- Manage Diabetes
Use TIR In Clinical Practice
For A Data-Driven Approach.
- Real Patients On TIR
Hear Empowering Stories
From Patients On Time In Range.
- What Is Time In Range?
Search results
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 3 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
Why This Biotech Stock Crashed 67% To A Two-Year Low
Investor's Business Daily· 16 hours agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA noted there were possible
Common low-calorie sweetener linked to heart attack and stroke, study finds
CNN via Yahoo News· 1 day agoA common low-calorie sweetener called xylitol, found in gum, candy, toothpaste and more, may cause...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 18 hours ago(NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows the...
U.S. FDA places clinical hold on Biomea's diabetes trials
Reuters via AOL· 1 day agoThe drug, BMF-219, was being tested in an early-to-mid stage study for type 2 diabetes and a...
U.S. FDA places hold on Biomea's diabetes trials
Reuters· 1 day agoBiomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing mid ...
Biomea Fusion Down 61% on Clinical Hold for Diabetes Drug
Morningstar· 1 day agoBiomea Fusion shares fell 61% to $4.40 after hours as the company said the Food and Drug Administration placed a full ...
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 14 hours agoand Rep. Pramila Jayapal (D-Wash.) this week wrote to eight pharmaceutical company CEOs, urging them...
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?
InvestorPlace· 17 hours agoBiomea Fusion (NASDAQ:BMEA) stock is falling hard on Friday after announcing a clinical hold has been put on its Phase I/II clinical trials of BMF-219....
U.S. FDA places hold on Biomea's diabetes trials
Reuters via Yahoo News· 1 day ago(Reuters) - Biomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ...